Skip to main content

Research Repository

Advanced Search

A phase II, randomised feasibility trial of a tailored, home-based exercise programme on disease-free survival among early stage high-risk recurring cancers in Yorkshire

People Involved

Profile image of Professor Michael Lind

Professor Michael Lind M.J.Lind@hull.ac.uk
Foundation Professor of Oncology/ Head of the Joint Centre for Cancer Studies

Profile image of Professor John Saxton

Professor John Saxton John.Saxton@hull.ac.uk
Professor in Clinical Exercise Physiology and Head of the School of Sport, Exercise & Rehabilitation Sciences

Dr Elizabeth Mitchell

Project Description

To determine the effect exercise has on preventing secondary cancers and improving 5-year survival rates among people diagnosed with breast, bowel, lung, or prostate cancers in Yorkshire.

Status Project Live
Value £932,740.00
Project Dates Sep 1, 2022 - Aug 31, 2026

You might also like

TRANSFORM: Reducing Inequalities in Cancer Outcomes in Yorkshire: Realising our potential for innovation in Diagnosis, Patient Management, Survivorship and Palliative Care Research Sep 1, 2017 - Dec 31, 2026
The death rate is higher in Yorkshire than the rest of England resulting in about 200 extra deaths each year of which more than half are in Hull. There are other significant cancer outcome inequalities between different groups; for example poorer pe... Read More about TRANSFORM: Reducing Inequalities in Cancer Outcomes in Yorkshire: Realising our potential for innovation in Diagnosis, Patient Management, Survivorship and Palliative Care Research.

PEOPLE: Primary care and community Engagement to Optimise time to Presentation with Lung cancEr symptoms in HULL Jun 1, 2017 - Jun 30, 2023
More people are diagnosed with and die from lung cancer in Hull than any other place in Yorkshire. Our aim is to improve earlier diagnosis of lung cancer by [1] getting people to see their doctor if they get lung symptoms and [2] getting GPs to refe... Read More about PEOPLE: Primary care and community Engagement to Optimise time to Presentation with Lung cancEr symptoms in HULL.

LIPS: A prospective registry-based cohort study to monitor the diagnosis and management of acute leukaemia in pregnancy Jun 1, 2018 - Feb 28, 2022
Acute leukaemia (AL) is an aggressive but potentially curable cancer that can affect women of childbearing age. When a pregnancy is complicated by a diagnosis of AL, clinicians face a complex dilemma: to balance risking the mother’s survival through... Read More about LIPS: A prospective registry-based cohort study to monitor the diagnosis and management of acute leukaemia in pregnancy.